Paper Details

  1. Home
  2. Paper Details

A Meta-Analysis of 13 Randomized Trials on Traditional Chinese Medicine as Adjunctive Therapy for COVID-19: Novel Insights into Lianhua Qingwen.

Author: GuanHuizhen, LeiYi, XinWenqiang, YangBi-Cheng

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This study reviewed 13 research studies on the use of traditional Chinese medicine (TCM) in addition to standard medical care for treating COVID-19. The study found that combining TCM with Western medicine led to better overall outcomes, improved lung function, reduced cough, and a lower risk of becoming severely ill. Specifically, one TCM formula called Lianhua Qingwen (LQ) showed significant benefits. However, the study acknowledges limitations and calls for larger and more rigorous studies to confirm these findings.
Paper Details　
Original Abstract of the Article :
The efficacy and safety of traditional Chinese medicine (TCM) paired with western medicine in the treatment of patients with COVID-19 remains controversial. This meta-analysis was performed to identify the effects of TCM. Seven electronic databases were reviewed from the inception of these databases...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637467/

データ提供：米国国立医学図書館（NLM）

Traditional Chinese Medicine for COVID-19: A Journey Through the Ancient Desert of Healing

We're on a quest to discover the secrets hidden in the ancient desert of Traditional Chinese Medicine (TCM). This meta-analysis, like a seasoned caravan leader navigating the treacherous dunes, systematically analyzed 13 randomized controlled trials (RCTs) investigating the efficacy of TCM as an adjunctive therapy for COVID-19. This comprehensive review, like a map guiding our exploration, aims to clarify the effectiveness and safety of TCM in the modern context of a global pandemic.

A Beacon of Hope: TCM as a Potential Oasis in the COVID-19 Desert

The results, like a shimmering oasis in the heart of the desert, suggest that TCM, when combined with Western medicine, may provide significant benefits for COVID-19 patients. The meta-analysis revealed that TCM groups exhibited higher rates of overall effectiveness, improved chest CT scans, and cough relief. Crucially, TCM also reduced the rate of patients developing severe conditions. One specific TCM formula, Lianhua Qingwen (LQ), showed particularly promising results.

Navigating the COVID-19 Desert with Ancient Wisdom

This research, like a well-worn path through the desert, suggests that TCM could play a valuable role in managing COVID-19, alongside traditional Western medicine. The study highlights the need for further investigation, like searching for hidden oases, to refine our understanding of TCM's effectiveness and safety, especially in the context of complex and evolving diseases like COVID-19.

Dr.Camel's Conclusion

As we navigate the vast and ever-changing desert of COVID-19, TCM offers a promising and potentially valuable tool. This research, like a map guiding our journey, suggests that the ancient wisdom of TCM could hold valuable keys to better understanding and managing this pandemic. However, as with all journeys through the desert, continued exploration and rigorous scientific investigation are crucial to ensure the safety and effectiveness of these traditional practices.

Date :
  1. Date Completed 2022-11-10
  2. Date Revised 2023-03-28
Further Info :

Pubmed ID

36349317

DOI: Digital Object Identifier

PMC9637467

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.